Literature DB >> 16952576

Prognostic value of KIT exon 11 deletions in GISTs.

Jean-François Emile, Séverine Tabone-Eglinger, Nathalie Théou-Anton, Antoinette Lemoine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16952576     DOI： 10.1053/j.gastro.2006.07.042

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  9 in total

1.  Prognostic value of mutational characteristics in gastrointestinal stromal tumors: a single-center experience in 275 cases.

Authors:  Ming Wang; Jia Xu; Wenyi Zhao; Lin Tu; Weiqing Qiu; Chaojie Wang; Yangyin Shen; Qiang Liu; Hui Cao
Journal:  Med Oncol       Date:  2013-12-14       Impact factor: 3.064

2.  A meta-analysis of prognostic value of KIT mutation status in gastrointestinal stromal tumors.

Authors:  Zhiqiang Jiang; Jian Zhang; Zhi Li; Yingjun Liu; Daohai Wang; Guangsen Han
Journal:  Onco Targets Ther       Date:  2016-06-03       Impact factor: 4.147

3.  Relationship between efficacy of sunitinib and KIT mutation of patients with advanced gastrointestinal stromal tumors after failure of imatinib: A systematic review.

Authors:  Fuming Xie; Weidong Xiao; Yahui Jiang; Xiao Xia; Yaxu Wang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Prognosis and predictive value of KIT exon 11 deletion in GISTs.

Authors:  J-B Bachet; I Hostein; A Le Cesne; S Brahimi; A Beauchet; S Tabone-Eglinger; F Subra; B Bui; F Duffaud; P Terrier; J-M Coindre; J-Y Blay; J-F Emile
Journal:  Br J Cancer       Date:  2009-06-16       Impact factor: 7.640

5.  Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors.

Authors:  Jean-Baptiste Bachet; Jean-François Emile
Journal:  Appl Clin Genet       Date:  2010-10-29

6.  Six years survival on imatinib with no disease progression after diagnosis of metastatic duodenal gastrointestinal stromal tumour: a case report.

Authors:  Sayantan Bhattacharya; Amit Kumar Choudhury; Srinivasan Ravi; John Morrissey; George Mathew
Journal:  J Med Case Rep       Date:  2008-04-18

7.  Involvement of c-KIT mutation in the development of gastrointestinal stromal tumors through proliferation promotion and apoptosis inhibition.

Authors:  Ying-Yu Ma; Sheng Yu; Xu-Jun He; Yuan Xu; Fang Wu; Ying-Jie Xia; Kun Guo; Hui-Ju Wang; Zai-Yuan Ye; Wei Zhang; Hou-Quan Tao
Journal:  Onco Targets Ther       Date:  2014-05-02       Impact factor: 4.147

Review 8.  Clinicopathological significance of c-KIT mutation in gastrointestinal stromal tumors: a systematic review and meta-analysis.

Authors:  Lin Yan; Lei Zou; Wenhua Zhao; Yansen Wang; Bo Liu; Hongliang Yao; Haihua Yu
Journal:  Sci Rep       Date:  2015-09-09       Impact factor: 4.379

9.  KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors.

Authors:  Grazia Palomba; Panagiotis Paliogiannis; Maria C Sini; Maria Colombino; Milena Casula; Antonella Manca; Marina Pisano; Giovanni Sotgiu; Valentina Doneddu; Giuseppe Palmieri; Antonio Cossu
Journal:  Eur J Cancer Prev       Date:  2021-01       Impact factor: 2.164
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.